Brief: Prostatype Q4 EBITDA Loss SEK 7.7 Million
Feb 16 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q4 NET SALES 304 (0) TSEK
* Q4 EBITDA LOSS SEK 7.7 MILLION VERSUS LOSS SEK 5.7 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr3N2HRD
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue